Loading clinical trials...
Loading clinical trials...
Phase III Study to Evaluate the Optimal Timing of Postoperative Radiotherapy for High Risk of Locoregional Recurrence Patients With Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer
Conditions
Interventions
PORT-first
PORT-last
+1 more
Locations
1
China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Start Date
November 1, 2016
Primary Completion Date
February 1, 2024
Completion Date
February 1, 2024
Last Updated
June 12, 2024
NCT07138755
NCT07339774
NCT07332000
NCT06719440
NCT07325721
NCT05926765
Lead Sponsor
Shanghai Chest Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions